Table 1.
Baseline characteristics of patients retained and LTFU in a retrospective chart review study of patients with type 2 diabetes mellitus
| Variable Name | Category | Retained N (col %) 128 (7%) | LTFU N (col %) 1690 (93%) | Chi-Square P-value |
|---|---|---|---|---|
| Socio-demographic characteristics | ||||
| Sex | 0.016 | |||
| Female | 88 (69) | 978 (58) | ||
| Male | 40 (31) | 712 (42) | ||
| Median age (IQR) (years) | Age | 60 (50–68) | 53 (44–64) | < 0.001 |
| Age group (years) | 0.001 | |||
| 19–44 | 15 (12) | 439 (26) | ||
| 45–64 | 68 (53) | 831 (49) | ||
| Above 64 | 45 (35) | 420 (25) | ||
| Residence | 0.966 | |||
| Rural | 14 (11) | 193 (12) | ||
| Peri-urban | 33 (26) | 422 (24) | ||
| Urban | 81 (63) | 1075 (64) | ||
| Education level | 0.23 | |||
| <=Primary Education | 50 (39) | 753 (45) | ||
| Secondary | 53 (41) | 574 (34) | ||
| Post-Secondary | 25 (20) | 363 (21) | ||
| Socioeconomic status | 0.107 | |||
| Lower | 22 (17) | 408 (24) | ||
| Middle | 58 (45) | 771 (46) | ||
| Upper | 48 (38) | 511 (30) | ||
| Life style characteristics | ||||
| Smoking | 0.19 | |||
| No | 119 (93) | 1509 (89) | ||
| Yes | 9 (7) | 181 (11) | ||
| Alcohol | 0.646 | |||
| No | 93 (73) | 431 (26) | ||
| Yes | 35 (27) | 1259 (74) | ||
| DM treatment characteristics | ||||
| Life style alone | 0.176 | |||
| No | 127 (99) | 1637 (97) | ||
| Yes | 1 (1) | 53 (3) | ||
| Lifestyle and monotherapy | 0.03 | |||
| No | 106 (83) | 1254 (74) | ||
| Yes | 22 (17) | 436 (26) | ||
| Lifestyle and dual therapy | 0.006 | |||
| No | 40 (31) | 740 (44) | ||
| Yes | 88 (69) | 950 (56) | ||
| Lifestyle and triple therapy | 0.359 | |||
| No | 115 (90) | 1557 (92) | ||
| Yes | 13 (10) | 133 (8) | ||
| Lifestyle and combination injection therapy | 0.037 | |||
| No | 122 (95) | 1514 (90) | ||
| Yes | 6 (5) | 176 (10) | ||
| DM complications and comorbidities | ||||
| Neuropathy | < 0.001 | |||
| No | 54 (42) | 1141 (68 | ||
| Yes | 74 (58) | 549 (32)) | ||
| Nephropathy | 0.005 | |||
| No | 114 (89) | 1605 (95) | ||
| Yes | 14 (11) | 85 (5) | ||
| Retinopathy | 0.01 | |||
| No | 94 (73) | 1394 (82) | ||
| Yes | 34 (27) | 296 (18) | ||
| Macroangiopathy | 0.003 | |||
| No | 120 (94) | 1654 (98) | ||
| Yes | 8 (6) | 36 (2) | ||
| Diabetic foot | 0.038 | |||
| No | 116 (91) | 1604 (95) | ||
| Yes | 12 (9) | 86 (5) | ||
| Hypoglycaemia | 0.095 | |||
| No | 122 (95) | 1651 (98) | ||
| Yes | 6 (5) | 39 (2) | ||
| Hypertension | 0.001 | |||
| No | 26 (20) | 593 (35) | ||
| Yes | 102 (80) | 1097 (65) | ||
| Erectile dysfunctiona | < 0.001 | |||
| No | 23 (57) | 576 (81) | ||
| Yes | 17 (43) | 136 (19) | ||
| Fasting plasma glucose (Mmol/l) | 0.955 | |||
| Controlled glycaemia | 35 (27) | 466 (28) | ||
| Hyperglycaemia | 93 (73) | 1224 (72) | ||